Ken Griffin Cognition Therapeutics Inc Call Options Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CGTX
# of Institutions
48Shares Held
7.6MCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$1.1 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$573,7770.0% of portfolio
-
Awm Investment Company, Inc. New York, NY650KShares$325,0000.17% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$250,0000.01% of portfolio
-
Timelo Investment Management Inc.361KShares$180,6980.35% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $11.4M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...